Harold E. Selick, Ph.D. is listed as a director on 2 SEC Form D filings by 2 issuers between Jun 2010 and Jul 2015: Intekrin Therapeutics Inc (Los Altos, CA — pharmaceuticals — 2010; $21.4M reported sold to 12 investors) and Protagonist Therapeutics, Inc (Milpitas, CA — biotechnology — 2015; $17.5M reported sold to 9 investors).
What this means 2 separate companies raised money with this person listed as director, over about 5 years. Across those companies the filings report $38.9M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Harold E. Selick, Ph.D. and found 7 differences: Bankruptcy case: David B Okun Corp Md Facp Mone v. Miles; Bankruptcy case: Community Bank v. Lanfear; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.